An 8-week, open-label study to characterize the response to modafinil (85-mg film-coated tablet) treatment at dosages up to 425mg/day in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) (with an open-ended extension period)

Trial Profile

An 8-week, open-label study to characterize the response to modafinil (85-mg film-coated tablet) treatment at dosages up to 425mg/day in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) (with an open-ended extension period)

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2007

At a glance

  • Drugs Modafinil (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Cephalon
  • Most Recent Events

    • 19 Nov 2007 Status changed from in progress to completed.
    • 28 Aug 2006 Status change
    • 09 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top